foxo4-dri peptide benefits 2MG/5MG/10MG VIAL – UMBRELLA Labs FOXO4-DRI — ≥99% Purity, COA

Florida Surgery & Weight Loss Center offers secure telehealth consultations for eligible patients throughout South Florida

What to Expect from Peptide Therapy Your journey begins with a comprehensive consultation to evaluate your health goals, injury history, and wellness needs

For 5 mg Vials: Peptide Vials (8 weeks): 23 vials (112 mg total) Peptide Vials (12 weeks): 34 vials (168 mg total) Peptide Vials (16 weeks): 45 vials (224 mg total) Bacteriostatic Water (10 mL bottles): Use 2.5 mL per vial For 10 mg Vials: Peptide Vials (8 weeks): 11 vials (105 mg total) Peptide Vials (12 weeks): 17 vials (161 mg total) Peptide Vials (16 weeks): 22 vials (217 mg total) Bacteriostatic Water (10 mL bottles): Use 3.0 mL per vial For 20 mg Vials: Peptide Vials (8 weeks): 6 vials (105 mg total) Peptide Vials (12 weeks): 9 vials (161 mg total) Peptide Vials (16 weeks): 11 vials (217 mg total) Bacteriostatic Water (10 mL bottles): Use 3.0 mL per vial Common Supplies for All Protocols: Insulin Syringes (U-100, 1 mL capacity): Per week: 7 syringes (1/day) 8 weeks: 56 syringes , 12 weeks: 84 syringes , 16 weeks: 112 syringes Alcohol Swabs: Per week: 14 swabs (2/day) 8 weeks: 112 swabs , 12 weeks: 168 swabs , 16 weeks: 224 swabs Protocol Overview Concise summary of the FDA-approved once-daily regimen

Since CagriSema contains semaglutide rather than tirzepatide, the transition involves switching GLP-1 agonists while adding an amylin component

Commonly associated with recovery, tissue repair and connective tissue research